Accessibility navigation


Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanisms

Ramprasath, T., Natarajan, N., Gopas, J., Subbiah, R., Rajendran, P. and Vaiyapuri, S. ORCID: https://orcid.org/0000-0002-6006-6517, eds. (2022) Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanisms. Frontiers in Pharmacology. Frontiers. (In Press)

[img] Text - Accepted Version
· Restricted to Repository staff only

365kB

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Abstract/Summary

During any infection or injury, inflammation plays a vital role in curing the injured tissues. However, uncontrolled inflammatory responses due to defects in pro-resolution and anti-inflammatory processes can be detrimental and lead to many diseases, including gastrointestinal, liver, lung and brain disorders. Although many approved anti-inflammatory drugs are currently in clinical use, long-term usage of anti-inflammatory drugs is associated with many side effects, including gastrointestinal toxicity and adverse effects on the cardiovascular system. Hence, understanding and advancing in the field of small molecules is a better way to tackle this clinical problem with anti-inflammatory drugs. This special issue has collectively published research and review articles focusing on inflammation and small molecule therapeutics with a larger perspective to generate ideas for future scientific and clinical research. We are hopeful that the small molecule-based therapeutic approaches discussed here will evolve more into routine clinical practice in near future.

Item Type:Book
Refereed:Yes
Divisions:Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Division of Pharmacology
ID Code:108937
Publisher:Frontiers

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation